Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group (Q74593419)
Jump to navigation
Jump to search
scientific article published on 01 March 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group |
scientific article published on 01 March 1999 |
Statements
Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group (English)
R L Theriault
A Lipton
G N Hortobagyi
R Leff
S Glück
J F Stewart
S Costello
I Kennedy
J Simeone
J J Seaman
R D Knight
K Mellars
M Heffernan
D J Reitsma
1 March 1999